Umbilical cord blood-derived allogeneic mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Umbilical cord blood-derived allogeneic mesenchymal stem cells, covering 2019-01-23 to 2019-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management [EARLY_Phase 1]